Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 3/20 | 0.40 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 4/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24466136 | 0.91 | ALOX5 (0.35) | ALOX5 | |
| SCHEMBL23155390 | 0.90 | ALOX5 (0.39) | ALOX5AHRDNMT1PRKDCPIK3CD | |
| SCHEMBL23155365 | 0.88 | ALOX5 (0.41) | ALOX5AHRPRKDCGGPS1ATM | |
| SCHEMBL23155230 | 0.87 | ALOX5 (0.39) | ALOX5AHRPRKDCGGPS1 | |
| SCHEMBL23155167 | 0.87 | MAPT (0.35) | ALOX5AHRKDM4EALDH1A1GAA | |
| SCHEMBL23155169 | 0.87 | DUSP3 (0.36) | ALOX5AHRKDM4EALDH1A1GAA | |
| SCHEMBL23155358 | 0.87 | L3MBTL1 (0.33) | ALOX5ALDH1A1HPGDHSD17B10DNMT1 | |
| SCHEMBL21141068 | 0.86 | ALOX5 (0.48) | ALOX5AHRKDM4EALDH1A1MAPT | |
| SCHEMBL23155156 | 0.86 | DNMT1 (0.40) | KDM4EALDH1A1GAAMAPTHPGD | |
| SCHEMBL23155231 | 0.85 | ALOX5 (0.41) | ALOX5AHRPRKDCGGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11594684-B2 | Condensed-cyclic compound and organic light emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-02-28 | — | — | US | disclosed |
| EP-3799144-B1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2022-06-01 | — | — | EP | disclosed |
| US-20210098700-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11594684-B2 | Condensed-cyclic compound and organic light emitting device including the same | CRY1, SMCHD1, CXCR1 | ALOX5 2879/4885AHR 1479/4885KDM4E 2359/4885 |
| US-20210098700-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | CRY1, SMCHD1, CXCR1 | ALOX5 2879/4885AHR 1479/4885KDM4E 2359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.